Neuroparalytic Illness and Human Diploid Cell Rabies Vaccine

Kenneth W. Bernard; Philip W. Smith; Fred J. Kader; Michael J. Moran

doi:10.1001/jama.1982.03330230048030

Neuroparalytic Illness and Human Diploid Cell Rabies Vaccine

Kenneth W. Bernard, Philip W. Smith, Fred J. Kader, Michael J. Moran

Research output: Contribution to journal › Article

44 Scopus citations

Abstract

An 11-year-old boy had a transient neuroparalytic illness that began three days after completing postexposure rabies prophylaxis with human diploid cell rabies vaccine (HDCV); he completely recovered within 12 weeks. Of 47,000 persons treated with HDCV in the United States from June 1980 through May 1982, this is the only verified case of neuroparalytic illness temporally associated with the vaccine administration. No cause-and-effect relationship was established.

Original language	English (US)
Pages (from-to)	3136-3138
Number of pages	3
Journal	JAMA: The Journal of the American Medical Association
Volume	248
Issue number	23
DOIs	https://doi.org/10.1001/jama.1982.03330230048030
State	Published - Dec 17 1982
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1001/jama.1982.03330230048030

Fingerprint Dive into the research topics of 'Neuroparalytic Illness and Human Diploid Cell Rabies Vaccine'. Together they form a unique fingerprint.

Cite this

Bernard, K. W., Smith, P. W., Kader, F. J., & Moran, M. J. (1982). Neuroparalytic Illness and Human Diploid Cell Rabies Vaccine. JAMA: The Journal of the American Medical Association, 248(23), 3136-3138. https://doi.org/10.1001/jama.1982.03330230048030

@article{ab2742ed64264d12b442afeb153341b3,

title = "Neuroparalytic Illness and Human Diploid Cell Rabies Vaccine",

abstract = "An 11-year-old boy had a transient neuroparalytic illness that began three days after completing postexposure rabies prophylaxis with human diploid cell rabies vaccine (HDCV); he completely recovered within 12 weeks. Of 47,000 persons treated with HDCV in the United States from June 1980 through May 1982, this is the only verified case of neuroparalytic illness temporally associated with the vaccine administration. No cause-and-effect relationship was established.",

author = "Bernard, {Kenneth W.} and Smith, {Philip W.} and Kader, {Fred J.} and Moran, {Michael J.}",

year = "1982",

month = dec,

day = "17",

doi = "10.1001/jama.1982.03330230048030",

language = "English (US)",

volume = "248",

pages = "3136--3138",

journal = "JAMA - Journal of the American Medical Association",

issn = "0002-9955",

publisher = "American Medical Association",

number = "23",

}

TY - JOUR

T1 - Neuroparalytic Illness and Human Diploid Cell Rabies Vaccine

AU - Bernard, Kenneth W.

AU - Smith, Philip W.

AU - Kader, Fred J.

AU - Moran, Michael J.

PY - 1982/12/17

Y1 - 1982/12/17

N2 - An 11-year-old boy had a transient neuroparalytic illness that began three days after completing postexposure rabies prophylaxis with human diploid cell rabies vaccine (HDCV); he completely recovered within 12 weeks. Of 47,000 persons treated with HDCV in the United States from June 1980 through May 1982, this is the only verified case of neuroparalytic illness temporally associated with the vaccine administration. No cause-and-effect relationship was established.

AB - An 11-year-old boy had a transient neuroparalytic illness that began three days after completing postexposure rabies prophylaxis with human diploid cell rabies vaccine (HDCV); he completely recovered within 12 weeks. Of 47,000 persons treated with HDCV in the United States from June 1980 through May 1982, this is the only verified case of neuroparalytic illness temporally associated with the vaccine administration. No cause-and-effect relationship was established.

UR - http://www.scopus.com/inward/record.url?scp=0020468067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020468067&partnerID=8YFLogxK

U2 - 10.1001/jama.1982.03330230048030

DO - 10.1001/jama.1982.03330230048030

M3 - Article

C2 - 7143690

AN - SCOPUS:0020468067

VL - 248

SP - 3136

EP - 3138

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 23

ER -